UNSPSC 85742554: Removal of nonautologous tissue substitute from fallopian tube, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of nonautologous tissue substitute from fallopian tube, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0UP84KZ

UNSPSC 85742554 (Removal of nonautologous tissue substitute from fallopian tube, percutaneous endoscopic approach), a Commodity code, shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific surgical procedure, but the recent opportunities tagged under it reflect administrative medical services, occupational health surveillance, pharmacy benefit management, and temporary staffing—none involving the fallopian tube procedure the code names. The City of Phoenix Retirement Office sought independent medical evaluation services for disability pension determinations; the Washington State Department of Transportation sought occupational medical surveillance for ferry workers; the City of Long Beach sought surgical carve-out networks for Centers of Excellence across orthopedic, cardiac, spine, and oncology specialties; and Santa Clara County Health System sought temporary staffing across ancillary clinical roles. The code appears to be a tagging error in state and local procurement systems rather than a category under active procurement.

The geographic spread of recent activity touches Arizona, Washington, California, and Florida, but the opportunities themselves do not represent genuine procurement under the code's commodity description. Harris County issued an RFI for emergency and specialty medical services for detained youth, and Collier County issued an RFP for pharmacy benefit management covering approximately 2,400 employees and 4,800 covered members with approximately $8.7 million in annual historical spend. Without recent opportunities authentically aligned to fallopian tube surgery or removal of tissue substitutes from reproductive organs, the code presents no actionable pursuit signal for business development professionals.